Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD
Inhaled Corticosteroids do Not Modify the Systemic Inflammation Induced by Exercise in Patients With Chronic Obstructive Pulmonary Disease
  • Phase

    Phase 4
  • Study Type

  • Status

    Completed No Results Posted
  • Intervention/Treatment

    fluticasone ...
  • Study Participants

Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary and systemic inflammation. The effect of inhaled corticosteroids (IC) on inflammation in COPD is controversial.
Physical exercise produces a systemic inflammatory response, both in the healthy individual and in the COPD patient (Rabinovitch et al ERJ 2003; van Helvoort et al Respir Med 2005; Davidson WJ et al. J Appl Physiol). Nevertheless, although it has been described that some of the systemic biomarkers related with COPD (Protein C-Reactive (PCR), interleukin [IL]-8) are associated with a lower tolerance to exercise in COPD patients (García-Río et al. Respir Res 2010), the role of IC on systemic inflammation triggered by exercise in COPD patients remains unknown.

This study explores the hypothesis that the inflammatory response induced by exercise in COPD patients could be with IC treatment.
Study Started
Feb 29
Primary Completion
Nov 30
Study Completion
Nov 30
Last Update
Aug 06

Drug Fluticasone

Administration of inhaled corticosteroids (fluticasone, 0.5 mg) each 12 hours to 8 of the 16 COPD patients versus placebo.

  • Other names: Inhaled Corticosteroids

Drug Inhaled Placebo

Inhaled Placebo Placebo Comparator

Inhaled placebo administered to healthy (n=7) and to a half (n=8) of COPD patients

Inhaled corticosteroids (Fluticasone, 0.5 mg) Experimental

Inhaled corticosteroids administered to the other half (n=8) of COPD patients


Inclusion Criteria:

ex-smokers (> 10 packets-year) with moderate-severe COPD patients
No Results Posted